SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-022967
Filing Date
2024-09-05
Accepted
2024-09-05 17:57:00
Documents
1
Period of Report
2024-09-03

Document Format Files

Seq Description Document Type Size
1 form4-09052024_090956.html 4  
1 form4-09052024_090956.xml 4 4096
  Complete submission text file 0001415889-24-022967.txt   5640
Mailing Address C/O AXOVANT SCIENCES, INC. 320 WEST 37TH STREET, 5TH FLOOR NEW YORK NY 10018
Business Address
FALBERG KATHRYN E (Reporting) CIK: 0001206977 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39351 | Film No.: 241282406

Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Issuer) CIK: 0001811063 (see all company filings)

IRS No.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)